Deubiquitinase USP24 activated by IL-6/STAT3 enhances PD-1 protein stability and suppresses T cell antitumor response

Hung-Chia Hsieh1, Ming-Jer Young2, Kuan-Yu Chen3

  • 1Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.

Science Advances
|April 16, 2025
PubMed

Insights

Ubiquitin-specific peptidase 24 (USP24) stabilizes programmed cell death-1 (PD-1) in T cells, driving exhaustion and immunotherapy failure. Inhibiting USP24 restores T cell function and enhances cancer treatment efficacy.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Persistent programmed cell death-1 (PD-1) signaling contributes to T cell exhaustion and immunotherapy resistance.
  • The precise mechanisms regulating PD-1 deubiquitination and subsequent T cell dysfunction are not fully understood.

Purpose of the Study:

  • To elucidate the role of ubiquitin-specific peptidase 24 (USP24) in PD-1 protein stability and T cell function.
  • To investigate USP24 as a potential therapeutic target for enhancing cancer immunotherapy.

Main Methods:

  • Investigated the deubiquitinating activity of USP24 on PD-1 using biochemical assays.
  • Utilized cell-based assays and genetically modified mouse models (including catalytic-deficient mice) to study USP24 function in T cells and lung tumorigenesis.
  • Administered USP24-specific inhibitors and combination immunotherapies (anti-CTLA4) in preclinical models.
  • Analyzed clinical samples from lung cancer patients to correlate USP24 expression with T cell exhaustion and immunotherapy response.

Main Results:

  • USP24 deubiquitinates PD-1 by removing K48-linked polyubiquitin, thereby stabilizing the PD-1 protein.
  • Interleukin-6 (IL-6) upregulates USP24 expression, leading to increased PD-1 stability.
  • USP24 deficiency in mice reduced PD-1 levels in CD8+ T cells and attenuated EGFR-driven lung tumorigenesis.
  • A USP24-specific inhibitor (USP24-i-101) enhanced cytotoxic T cell activity, suppressed tumor growth, and improved outcomes when combined with anti-CTLA4 therapy.
  • High USP24 expression in tumor-infiltrating CD8+ T cells from lung cancer patients correlated with T cell exhaustion and poor immunotherapy response.

Conclusions:

  • USP24 plays a critical role in maintaining PD-1 stability within tumor-infiltrating CD8+ T cells.
  • USP24 represents a novel therapeutic target for overcoming T cell exhaustion and improving the efficacy of cancer immunotherapy, particularly in lung cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.4K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.3K